Select your country
Select a country to go to the website of the respective STADA sales company.
United Kingdom (4)
STADA: Statement on media reports
- Press Release
- Investor News
STADA confirms current media reports that the expert sessions which were planned as part of the structured bidding process have been postponed based on the decision of the Supervisory Board. The Executive Board and the Supervisory Board mutually agree that the indicative bids do not yet reflect the fundamental value of STADA. Thus, the company, for the time being, wants to provide the bidders the opportunity to increase their offers.
STADA objects current media reports that the delay in the process is aimed to make another committee composed of a private equity company and a strategic investor enter the process.
Additional information for analysts:
STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2–18 / 61118 Bad Vilbel – Germany / Tel.: +49 (0) 6101 603-173 / Fax: +49 (0) 6101 603-215 / E-mail: email@example.com